Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |